Companies: 10,795·Total market cap: $144.5T
Amgen Inc.

Amgen Inc.

AMGNNASDAQHealthcare● Active
$349.58
+$3.98(+1.15%)
Market Cap$188.7B
P/E Ratio
52W High$391.29
52W Low$267.83

Amgen Inc. (AMGN) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

amgn · stock forecast · 38 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 38 Wall Street analysts in the past 3 months

SellBuy

Buy

38 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
22
Hold
13
Sell
3
Strong Sell
0
Total: 38 · Buy rate: 57.9%

12-Month Price Target

High

$427

Consensus

$353

+1.0% upside

Low

$185

Median: $357.5 · Last Close: $349.58

The Amgen Inc. (AMGN) analyst consensus is Buy, based on ratings from 38 Wall Street analysts over the past 3 months. The average 12-month AMGN price target is $353.06, representing +1.0% upside from the current price of $349.58.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $353 (1.0%)

Consensus Target

$353.06

1.0% upside

High Target

$427

22.1%

Low Target

$185

-47.1%

Current Price

$349.58

as of today

Based on analyst price targets, the AMGN stock price prediction for the next 12 months ranges from $185 to $427. The consensus AMGN price forecast of $353.06 implies 1.0% upside from the current price of $349.58.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$351.070.43%

1-day model range: $350.01–$352.14. Peak: $352.14 (+0.43%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$430+22.9%
2028$494+41.2%
2029$541+54.8%
2030$575+64.6%
2031+71.3%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

86%0%14%
12Buy
0Neutral
2Sell
RSI (14)72.9Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · AMGN · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$338.16BUY
MA 10$337.54BUY
MA 20$334.80BUY
MA 50$340.69BUY
MA 100$350.76SELL
MA 200$329.36BUY
Current $AMGN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$341.79BUY
EMA 10$338.55BUY
EMA 20$337.13BUY
EMA 50$340.73BUY
EMA 100$341.30BUY
EMA 200$332.59BUY
Current $AMGN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Piper Sandler2026-05-14
Maintains
OverweightOverweight
Guggenheim2026-05-04
Maintains
NeutralNeutral
Truist Securities2026-05-01
Maintains
HoldHold
UBS2026-04-13
Maintains
BuyBuy
Morgan Stanley2026-04-10
Maintains
Equal WeightEqual Weight
Guggenheim2026-04-09
Maintains
NeutralNeutral
Cantor Fitzgerald2026-04-08
Maintains
NeutralNeutral
Wells Fargo2026-02-19
Maintains
Equal WeightEqual Weight
Piper Sandler2026-02-18
Maintains
OverweightOverweight
Freedom Broker2026-02-12
Downgrade ↓
BuyHold

Wall Street analysts have recently issued updated ratings on Amgen Inc. (AMGN) stock. Of the recent 359 rating actions, 35 were upgrades and 28 were downgrades. 38 analysts currently cover AMGN.

Analyst Recommendation Trends

Buy ratings312
Hold ratings321
Sell ratings00

AMGN analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$37.8B

↓ 4.9% YoY

Revenue Next Year

$38.8B

↑ 2.6% YoY

EPS This Year

$22.39

EPS Next Year

$23.45

↑ 4.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast AMGN EPS of $22.39 for the current fiscal year, based on estimates from 20 analysts. The AMGN revenue forecast is $37.8B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The AMGN stock forecast is supported by two independent data sources: analyst consensus ratings from 38 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AMGN price target is $353.06 (+1.0% upside), with an analyst consensus of Buy.

The AMGN short-term stock prediction for tomorrow is $351.07 (+0.43%). The AMGN stock price prediction for 2027 estimates an average of $430. The AMGN stock prediction for 2030 projects a range of $556–$594.

Amgen Inc. trades on NASDAQ under the ticker AMGN. The AMGN stock outlook for 2027 is broadly positive, supported by a Buy consensus among 58% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

AMGN forecast · 8 questions

According to 38 Wall Street analysts, the average 12-month AMGN price target is $353.06, with a high forecast of $427.00 and a low of $185.00. The median price target is shown in the chart above when available. This implies +1.0% potential upside from the current price of $349.58.

AMGN price targetWhat is AMGN price targetAMGN analyst price targetAMGN 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.